SEOUL, SOUTH KOREA - Media OutReach Newswire - 9 July 2025 - Health2Sync, Asia's leading digital chronic disease management platform, announced the successful integration of Smart Cap Mallya® for ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly injectable using a user-friendly FlexTouch pen.

Levemir (insulin detemir) is safe to receive while pregnant or breastfeeding. However, factors such as the form you get or the condition the drug helps treat may determine whether you should receive ...

As a special education teacher living with Type 1 diabetes in Crawfordsville, I’ve relied on insulin to manage my condition since my diagnosis in 2011. Despite my engagement as an #insulin4all ...

Senate Democrats are meeting with Novo Nordisk executives to address the decision to stop selling a long-acting insulin in the country; research is attempting to prove the health benefits of new ...

London: Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long-acting insulins in the country, two sources ...

When announcing in November the discontinuation of Levemir in the U.S., Novo Nordisk cited manufacturing constraints, reduced patient access and available alternatives -- including its other ...

LONDON/WASHINGTON (Reuters) -Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long-acting insulins in the ...

The scarcity of insulin is causing stress among those with type 1 diabetes. Reports of insulin scarcity have sparked concerns among patients, including one NHS doctor who shared her struggle to obtain ...